Next Article in Journal
Anti-Inflammatory Diets and Fatigue
Next Article in Special Issue
Dietary Determinants of Metabolic Syndrome Parameters Differ by Gender in College Students
Previous Article in Journal
Effect of Caffeine Supplementation on Sports Performance Based on Differences Between Sexes: A Systematic Review
Previous Article in Special Issue
Phaseolus vulgaris L. Extract: Alpha-Amylase Inhibition against Metabolic Syndrome in Mice
Review

Health-Promoting Properties of Selected Cyclitols for Metabolic Syndrome and Diabetes

1
Department of Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, 10-082 Olsztyn, Poland
2
Department of Plant Physiology, Genetics and Biotechnology, University of Warmia and Mazury in Olsztyn, 10-229 Olsztyn, Poland
3
Department of Cardiology and Cardiosurgery, School of Medicine, Collegium Medicum University of Warmia and Mazury, 10-082 Olsztyn, Poland
*
Authors to whom correspondence should be addressed.
Received: 16 July 2019 / Revised: 17 September 2019 / Accepted: 24 September 2019 / Published: 30 September 2019
(This article belongs to the Special Issue Diet and Metabolic Syndromes)
Cyclitols play a particularly important role in cell functioning because they are involved in ion channel physiology, phosphate storage, signal transduction, cell wall formation, membrane biogenesis, osmoregulation and they have antioxidant activity. They are involved in the cell membranes as a phosphatidyl myo-inositol, an inositol triphosphate precursor, which acts as a transmitter that regulates the activity of several hormones, such as follicle-stimulating hormone, thyrotropin, and insulin. The aim of this paper is to characterize the selected cyclitols: myo-inositol, D-chiro-inositol, and D-pinitol in type-2 metabolic syndrome and diabetes treatment. Results and discussion: Cyclitols have certain clinical applications in the treatment of metabolic syndromes and are considered to be an option as a dietary supplement for the treatment or prevention of gestational diabetes mellitus and type-2 diabetes. Improved metabolic parameters observed after using cyclitols, like myo-inositol, in the treatment of polycystic ovary syndrome and type-2 diabetes suggest that they may have a protective effect on the cardiovascular system. Pinitol, together with myo-inositol,maybe responsible for improving lipid profiles by reducing serum triglyceride and total cholesterol. Pinitol is also well-researched and documented for insulin-like effects. Myo-inositol, D-chiro-inositol, and D-pinitol indicate a number of therapeutic and health-promoting properties. View Full-Text
Keywords: myo-inositol; D-chiro-inositol; D-pinitol; metabolic syndrome; diabetes myo-inositol; D-chiro-inositol; D-pinitol; metabolic syndrome; diabetes
Show Figures

Figure 1

MDPI and ACS Style

Antonowski, T.; Osowski, A.; Lahuta, L.; Górecki, R.; Rynkiewicz, A.; Wojtkiewicz, J. Health-Promoting Properties of Selected Cyclitols for Metabolic Syndrome and Diabetes. Nutrients 2019, 11, 2314. https://0-doi-org.brum.beds.ac.uk/10.3390/nu11102314

AMA Style

Antonowski T, Osowski A, Lahuta L, Górecki R, Rynkiewicz A, Wojtkiewicz J. Health-Promoting Properties of Selected Cyclitols for Metabolic Syndrome and Diabetes. Nutrients. 2019; 11(10):2314. https://0-doi-org.brum.beds.ac.uk/10.3390/nu11102314

Chicago/Turabian Style

Antonowski, Tomasz, Adam Osowski, Lesław Lahuta, Ryszard Górecki, Andrzej Rynkiewicz, and Joanna Wojtkiewicz. 2019. "Health-Promoting Properties of Selected Cyclitols for Metabolic Syndrome and Diabetes" Nutrients 11, no. 10: 2314. https://0-doi-org.brum.beds.ac.uk/10.3390/nu11102314

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop